Cargando…
375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control
BACKGROUND: Peru has one of the highest per capita SARS-CoV-2 death rates in Latin America. Healthcare workers (HCW) are a critical workforce during the COVID-19 pandemic but are themselves often at increased risk of infection. We evaluated SARS-CoV-2 attack rate and risk factors among frontline HCW...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644794/ http://dx.doi.org/10.1093/ofid/ofab466.576 |
_version_ | 1784610168789532672 |
---|---|
author | Westercamp, Matthew Soto, Giselle Smith, Rachel Azziz-Baumgartner, Eduardo Bollinger, Susan Castillo, Roger Cuentas, Alejandro Llanos Grogl, Max Olson, Natalie Prouty, Mike Matos, Eduardo Romero, Candice Silva, Marita Lessa, Fernanda C Lessa, Fernanda C Arriola, Carmen S |
author_facet | Westercamp, Matthew Soto, Giselle Smith, Rachel Azziz-Baumgartner, Eduardo Bollinger, Susan Castillo, Roger Cuentas, Alejandro Llanos Grogl, Max Olson, Natalie Prouty, Mike Matos, Eduardo Romero, Candice Silva, Marita Lessa, Fernanda C Lessa, Fernanda C Arriola, Carmen S |
author_sort | Westercamp, Matthew |
collection | PubMed |
description | BACKGROUND: Peru has one of the highest per capita SARS-CoV-2 death rates in Latin America. Healthcare workers (HCW) are a critical workforce during the COVID-19 pandemic but are themselves often at increased risk of infection. We evaluated SARS-CoV-2 attack rate and risk factors among frontline HCWs. METHODS: We performed a prospective cohort study of HCW serving two acute care hospitals in Lima, Peru from Aug 2020 to Mar 2021. Participants had baseline SARS-CoV-2 serology using the CDC ELISA, active symptom monitoring, and weekly respiratory specimen collection with COVID-19 exposure/risk assessment for 16-weeks regardless of symptoms. Respiratory specimens were tested by real-time reverse transcriptase PCR (rRT-PCR). RESULTS: Of 783 eligible, 667 (85%) HCW were enrolled (33% nurse assistants, 29% non-clinical staff, 26% nurses, 7% physicians, and 6% other). At baseline and prior to COVID-19 vaccine introduction, 214 (32.1%; 214/667) were reactive for SARS-CoV-2 antibodies. In total, 72 (10.8%; 72/667) HCWs were found to be rRT-PCR positive during weekly follow-up. Of the rRT-PCR positive HCWs, 37.5% (27/72) did not report symptoms within 1-week of specimen collection. During follow up, HCW without detectable SARS-CoV-2 antibodies at baseline were significantly more likely to be rRT-PCR positive (65/453, 14.3%) compared to those with SARS-CoV-2 antibodies at baseline (4/214, 1.9%) (p-value: < 0.001). Three HCW were both serologically reactive and rRT-PCR positive at baseline. Looking only at HCW without SARS-CoV-2 antibodies, nurse assistants (rRT-PCR positive: 18.6%; 27/141) and non-clinical healthcare workers (16.5%; 21/127) were at greater risk of infection compared to nurses (8.5%; 10/118), physicians (7.9%; 3/38), and other staff (10.3%; 4/29) (RR 1.95;95%CI 1.2,3.3; p-value: 0.01). CONCLUSION: Baseline SARS-CoV-2 prevalence and 16-week cumulative incidence were substantial in this pre-vaccination Peruvian HCW cohort. Almost 40% of new infections occurred in HCW without complaint of symptoms illustrating a limitation of symptom-based HCW screening for COVID-19 prevention. Nurse assistants and non-clinical healthcare workers were at greater risk of infection indicating a role for focused infection prevention and risk reduction strategies for some groups of HCW. DISCLOSURES: Fernanda C. Lessa, MD, MPH, Nothing to disclose |
format | Online Article Text |
id | pubmed-8644794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86447942021-12-06 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control Westercamp, Matthew Soto, Giselle Smith, Rachel Azziz-Baumgartner, Eduardo Bollinger, Susan Castillo, Roger Cuentas, Alejandro Llanos Grogl, Max Olson, Natalie Prouty, Mike Matos, Eduardo Romero, Candice Silva, Marita Lessa, Fernanda C Lessa, Fernanda C Arriola, Carmen S Open Forum Infect Dis Poster Abstracts BACKGROUND: Peru has one of the highest per capita SARS-CoV-2 death rates in Latin America. Healthcare workers (HCW) are a critical workforce during the COVID-19 pandemic but are themselves often at increased risk of infection. We evaluated SARS-CoV-2 attack rate and risk factors among frontline HCWs. METHODS: We performed a prospective cohort study of HCW serving two acute care hospitals in Lima, Peru from Aug 2020 to Mar 2021. Participants had baseline SARS-CoV-2 serology using the CDC ELISA, active symptom monitoring, and weekly respiratory specimen collection with COVID-19 exposure/risk assessment for 16-weeks regardless of symptoms. Respiratory specimens were tested by real-time reverse transcriptase PCR (rRT-PCR). RESULTS: Of 783 eligible, 667 (85%) HCW were enrolled (33% nurse assistants, 29% non-clinical staff, 26% nurses, 7% physicians, and 6% other). At baseline and prior to COVID-19 vaccine introduction, 214 (32.1%; 214/667) were reactive for SARS-CoV-2 antibodies. In total, 72 (10.8%; 72/667) HCWs were found to be rRT-PCR positive during weekly follow-up. Of the rRT-PCR positive HCWs, 37.5% (27/72) did not report symptoms within 1-week of specimen collection. During follow up, HCW without detectable SARS-CoV-2 antibodies at baseline were significantly more likely to be rRT-PCR positive (65/453, 14.3%) compared to those with SARS-CoV-2 antibodies at baseline (4/214, 1.9%) (p-value: < 0.001). Three HCW were both serologically reactive and rRT-PCR positive at baseline. Looking only at HCW without SARS-CoV-2 antibodies, nurse assistants (rRT-PCR positive: 18.6%; 27/141) and non-clinical healthcare workers (16.5%; 21/127) were at greater risk of infection compared to nurses (8.5%; 10/118), physicians (7.9%; 3/38), and other staff (10.3%; 4/29) (RR 1.95;95%CI 1.2,3.3; p-value: 0.01). CONCLUSION: Baseline SARS-CoV-2 prevalence and 16-week cumulative incidence were substantial in this pre-vaccination Peruvian HCW cohort. Almost 40% of new infections occurred in HCW without complaint of symptoms illustrating a limitation of symptom-based HCW screening for COVID-19 prevention. Nurse assistants and non-clinical healthcare workers were at greater risk of infection indicating a role for focused infection prevention and risk reduction strategies for some groups of HCW. DISCLOSURES: Fernanda C. Lessa, MD, MPH, Nothing to disclose Oxford University Press 2021-12-04 /pmc/articles/PMC8644794/ http://dx.doi.org/10.1093/ofid/ofab466.576 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Abstracts Westercamp, Matthew Soto, Giselle Smith, Rachel Azziz-Baumgartner, Eduardo Bollinger, Susan Castillo, Roger Cuentas, Alejandro Llanos Grogl, Max Olson, Natalie Prouty, Mike Matos, Eduardo Romero, Candice Silva, Marita Lessa, Fernanda C Lessa, Fernanda C Arriola, Carmen S 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control |
title | 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control |
title_full | 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control |
title_fullStr | 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control |
title_full_unstemmed | 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control |
title_short | 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control |
title_sort | 375. high laboratory-confirmed sars-cov-2 attack rate in lima health care personnel during august 2020-march 2021 suggests role for improved infection control |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644794/ http://dx.doi.org/10.1093/ofid/ofab466.576 |
work_keys_str_mv | AT westercampmatthew 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT sotogiselle 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT smithrachel 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT azzizbaumgartnereduardo 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT bollingersusan 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT castilloroger 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT cuentasalejandrollanos 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT groglmax 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT olsonnatalie 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT proutymike 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT matoseduardo 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT romerocandice 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT silvamarita 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT lessafernandac 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT lessafernandac 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol AT arriolacarmens 375highlaboratoryconfirmedsarscov2attackrateinlimahealthcarepersonnelduringaugust2020march2021suggestsroleforimprovedinfectioncontrol |